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ABSTRACT In 2011, the human pneumococcal standard reference serum, 007sp,
was established as a replacement for the previous standard, lot 89SF, supplies of
which were dwindling. The pneumococcal reference serum is used primarily in the
standardized pneumococcal enzyme-linked immunosorbent assay (World Health Or-
ganization reference enzyme-linked immunosorbent assay) but has also been used
in functional assays. Serotype-speciﬁc IgG values for 24 pneumococcal capsular sero-
types have previously been assigned to 007sp by bridging to the original values de-
rived for lot 89SF. In this study, by bridging to existing values in lot 89SF, we assign
weight-based serotype-speciﬁc IgA, IgG1, and IgG2 to 007sp for 11 pneumococcal
capsular serotypes (1, 3, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, and 23F), as well as serotype
19A-speciﬁc IgA. Concentrations for serotype-speciﬁc IgA, IgG1, and IgG2 present in
007sp were comparable to those previously assigned to lot 89SF. In addition, the
concentration of serotype-speciﬁc IgG1 plus IgG2 assigned to 007sp signiﬁcantly cor-
related to previously assigned 007sp IgG values. The accuracy of antibody assign-
ments to 007sp from lot 89SF was assessed by comparing the concentration of
serotype-speciﬁc IgA, IgG1, and IgG2 in 16 unknown samples using both 007sp and
lot 89SF as the standard. Interpolated values for the unknown samples were highly
correlated with average R2 values of 0.9729, 0.9951, and 0.9933 for IgA, IgG1, and
IgG2, respectively, for all serotypes demonstrating the precise nature assignments to
007sp made in this study. Nonparallelism between 007sp and lot 89SF has pre-
cluded the derivation of serotype-speciﬁc IgM values.
IMPORTANCE A well-characterized antibody standard is an indispensable reagent
for use in assays designed to measure antibodies with precision and where as-
says between laboratories need to be comparable. The human pneumococcal
standard reference serum, lot 89SF, greatly facilitated the standardization of
enzyme-linked immunosorbent assay methodologies during a critical period
when the ﬁrst pneumococcal polysaccharide-conjugate vaccines were being eval-
uated for licensure. Due to dwindling supplies of lot 89SF, a new reference stan-
dard, 007sp, was produced in 2011. Understanding the isotype and subclass
composition of either natural or vaccine induced responses to pathogens has as-
sumed increasing importance. In this study, we have assigned IgA, IgG1, and
IgG2 values to pneumococcal serotypes 1, 3, 4, 5, 6B, 7F, 9V, 14, 18C, 19A, 19F,
and 23F by bridging to existing values in lot 89SF.
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The human pneumococcal standard reference serum, lot 89SF, was a critical regentduring the standardization of enzyme-linked immunosorbent assay (ELISA) meth-
odologies at a critical period when the ﬁrst pneumococcal polysaccharide-conjugate
vaccines were being evaluated for licensure. Lot 89SF was used in serotype-speciﬁc
ELISAs designed to measure IgG antibody speciﬁc for individual pneumococcal capsular
polysaccharides. Serotype-speciﬁc weight-based values for IgA, IgG, and IgM in lot 89SF
were originally derived for serotypes 1, 3, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, and 23F by
Quataert et al. (1) and then extended to cover all serotypes in the 23-valent pneumo-
coccal polysaccharide vaccine (2). IgG1 and IgG2 serotype-speciﬁc values for serotypes
3, 6B, 14, 19F, and 23F were assigned to lot 89SF in 1998 (3) and to serotypes 1, 4, 5,
7F, 9V, and 18C in 2005 (3, 4). Due to dwindling supplies of lot 89SF, a new reference
standard, 007sp, was developed in 2011 (5). This serum was generated under an U.S.
Food and Drug Administration (FDA)-approved clinical protocol, in which 278 adult
volunteers were immunized with the 23-valent unconjugated polysaccharide vaccine,
Pneumovax II. To date, serotype-speciﬁc IgG concentrations have been assigned to
007sp for the 23 pneumococcal capsular serotypes that are in the 23-valent capsular
polysaccharide vaccine and serotype 6A (5–7). Values for IgA, IgM, and IgG subclasses
have not yet been assigned to 007sp.
Pneumococcal vaccination induces IgG, IgA, IgM, IgG1, and IgG2 responses. The
dominant isotype and serotype composition induced by vaccination varies depending
on type of vaccine used (pure polysaccharide versus conjugate) and with age (1, 8).
While circulating IgG has been correlated with serotype-speciﬁc protection against
invasive pneumococcal disease (IPD), there is still considerable uncertainty about the
exact effector mechanism(s) that mediate protection both against IPD and other
infection syndromes and nasopharyngeal carriage. To this end, it remains relevant to
have the appropriate reagents in place to estimate all serotype-speciﬁc isotypes and
IgG1 and IgG2 in the context of vaccination and natural immunity. Furthermore,
variable contribution of the isotypes induced by vaccination to functional immune
responses emphasize the relevance of being able to estimate serotype-speciﬁc anti-
bodies other than IgG (9, 10).
In this study, we assign preliminary serotype-speciﬁc concentrations of IgA, IgG1,
and IgG2 to the human pneumococcal standard reference serum, 007sp. The accuracy
of antibody assignments to 007sp bridged from lot 89SF was then assessed by
comparing the concentration of serotype-speciﬁc IgG1, IgG2, and IgA in 16 “unknown”
samples using previously assigned antibody values to lot 89SF and antibody values
assigned to 007sp in this study.
RESULTS
The consistency of antibody concentrations assigned to 007sp in this study was
assessed by calculating the coefﬁcient of variation (CV) between repeats for each
serotype. Repeats were highly consistent with CVs of 18% for IgA, IgG1, and IgG2.
Analysis of variance (ANOVA) models were used to estimate IgA, IgG1, and IgG2
antibody concentrations for each of the serotypes in 007sp. Values and 95% conﬁdence
intervals (CIs) were obtained by back-transforming the estimated log-transformed
concentrations and associated 95% CIs. Concentrations of IgA, IgG1, and IgG2 assigned
to 007sp for each serotype are shown in Table 1. These values were derived by the
double absorption of 007sp using pneumococcal cell wall polysaccharide (CWPS) and
puriﬁed serotype 22F polysaccharide and thus in future both standard and unknown
tests samples should be doubly adsorbed. Comparisons of IgA, IgG1, and IgG2 values
assigned to 007sp and the original values for lot 89SF are shown in Fig. 1. The
correlation of previously assigned serotype-speciﬁc IgG and IgG1 2 values assigned
to 007sp in this study was highly signiﬁcant with an R2 value of 0.9546, despite the fact
that the assays use different secondary antibodies of undetermined afﬁnities and are
thus not optimized for comparability to each other (Fig. 2). When assessing the relative
proportion of IgG1 and IgG2 binding to individual serotypes, for most serotypes the
response was dominated by IgG2 (average G1/G2 ratio, 1:12.9), which was similar to the
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ratio seen in lot 89SF (1:10.9). The only exception was serotype 3-speciﬁc IgG1, which
represented approximately 19% of the IgG response and was similar in 007sp to that
observed in lot 89SF (3).
The accuracy of antibody assignments to 007sp bridged from lot 89SF was assessed
by measuring the concentration of serotype-speciﬁc IgG1, IgG2, and IgA in 16 “un-
known” samples (FDA opsonophagocytic assay [OPA] calibration serum panel). Lot 89SF
and 007sp were used independently as the antibody standards, and the interpolated
serotype-speciﬁc antibody values were compared for each of the 16 unknown samples.
Scatter plots showing the correlation between the concentrations of serotype-speciﬁc
IgA, IgG1, and IgG2 in the panel of 16 sera using lot 89SF and 007sp for each antibody
are shown in Fig. 3. Coefﬁcients of variation between values interpolated using lot 89SF
and 007sp for all serotypes were 20%. The correlation (R2 values) between values
interpolated using lot 89SF and 007sp for all serotypes were0.95. The fold differences
between values interpolated using lot 89SF and 007sp for all serotypes were between
0.9 and 1.2. The geometric mean concentrations of each “unknown” sample tested are
detailed in Table S1 in the supplemental material.
DISCUSSION
A well-characterized antibody standard is an indispensable reagent for use in assays
designed to measure antibodies with precision and where assays between laboratories
need to be comparable. Understanding the isotype and subclass composition of either
natural or vaccine induced responses to pathogens has also assumed increasing
importance, particularly for pathogens that are found on mucosae such as in the
nasopharynx. 007sp was established when stocks of the existing internationally ac-
cepted human pneumococcal standard reference serum, lot 89SF, were depleted. After
manufacturing 007sp, initial efforts focused on assigning serotype-speciﬁc IgG levels
from those assigned to lot 89SF. With that complete, we have assigned to 007sp
weight-based serotype-speciﬁc IgA, IgG1, and IgG2 for 12 pneumococcal serotypes to
aid in the evaluation of the contribution of isotype and subclass to responses to
pneumococcal infection and vaccines. 19A assignment was only possible for IgA since
IgG1 and IgG2 antibody levels to 19A were never assigned to lot 89SF.
As expected, the concentration of serotype-speciﬁc IgA, IgG1, and IgG2 present
in 007sp were generally similar to those previously assigned to lot 89SF since both
standards were manufactured from the sera of adults immunized with pneumo-
coccal polysaccharide vaccine. The exceptions to this were the levels of serotype 3-
and 19A-speciﬁc IgA, which were higher in lot 89SF than in 007sp, and IgG1 speciﬁc
for 19F, which was higher in 007sp than in lot 89SF. These two standard sera were
established over a period of time separated by decades. Natural exposure to
pneumococcal serotypes in the United States cohorts immunized with the pneu-
mococcal polysaccharide vaccine to prepare 89SF and 007sp, respectively, will have
TABLE 1 Geometric mean concentrations of serotype-speciﬁc IgA, IgG1, and IgG2 (g/ml) in 007sp assigned by reference to lot 89SFa
Serotype
IgA IgG1 IgG2
GMC (g/ml) 95% CI n GMC (g/ml) 95% CI n GMC (g/ml) 95% CI n
1 1.879 1.86–1.91 40 0.976 0.90–1.537 20 8.866 7.133–11.019 20
3 1.893 1.83–1.98 40 0.807 0.73–1.199 20 3.503 3.166–3.877 20
4 1.266 1.24–1.29 40 0.325 0.30–0.511 19 3.142 1.967–5.021 20
5 1.103 1.08–1.12 40 0.262 0.24–0.388 20 9.731 6.129–15.45 20
6B 1.536 1.52–1.55 40 0.592 0.55–0.845 25 7.527 5.698–9.943 20
7F 1.734 1.70–1.77 40 0.500 0.42–1.617 18 7.726 5.657–10.552 20
9V 1.763 1.74–1.79 40 0.665 0.64–0.806 20 8.355 6.791–10.281 20
14 2.984 2.85–3.12 40 2.291 2.19–2.9 20 24.286 19.951–29.563 20
18C 0.708 0.693–0.723 40 0.456 0.41–0.869 19 6.749 4.277–10.65 20
19A 1.892 1.86–1.92 40
19F 1.655 1.62–1.69 40 1.623 1.51–2.393 20 13.142 8.373–20.626 20
23F 0.600 0.591–0.609 40 0.304 0.29–0.395 20 7.088 6.201–8.101 20
aThe geometric mean concentration (GMC), 95% conﬁdence interval, and number of replicates (n) for each assignment are shown.
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been very different since 89SF was made in the pre-PCV era, while 007sp was made
in the United States in 2009/10 after 10 years of PCV use in infants. IgG2 dominated
the response to all serotypes with the highest relative contribution being to
serotype 5 (97%).
The accuracy of antibody assignments to 007sp bridged from lot 89SF was assessed
by comparing the concentration of serotype-speciﬁc IgG1, IgG2, and IgA in 16 unknown
samples using both 007sp and lot 89SF as the standard. Interpolated values for the
unknown samples were highly correlated, with average R2 values of 0.9729, 0.9951, and
0.9933 for IgA, IgG1, and IgG2, respectively, for all serotypes. The fold differences
between the interpolated antibody values for the 16 unknown samples using both lot
89SF and 007sp were minimal and calculated to be between 0.9 and 1.2 for all
FIG 1 Comparison of the original assigned values for serotype-speciﬁc IgA (a), IgG1 (b), and IgG2 (c)
antibody in lot 89SF and those assigned to 007sp in this study. Each point represents the geometric
mean concentrations of serotype-speciﬁc antibody assigned to lot 89SF (crosses; solid line) and 007sp
(open circles, dashed line).
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serotypes. Finally, the coefﬁcients of variation between interpolated antibody values
were small and were calculated as 20% for all serotypes. These comparisons go some
way into proving the precise nature of the serotype-speciﬁc IgA, IgG1, and IgG2
assignments to 007sp made in this study.
Serotype-speciﬁc IgA antibody units remain to be assigned for 12 additional pneu-
mococcal serotypes assigned for lot 89SF. Nonparallelism between 007sp and lot 89SF
has thus far precluded the derivation of IgM-speciﬁc values for 007sp. In addition,
further work assigning serotype-speciﬁc IgM, IgA, IgG1, and IgG2 values to a panel of
World Health Organization (WHO) quality control sera for these capsular serotypes will
be undertaken in due course (5, 6). Previous weight-based serotype-speciﬁc antibody
value assignment studies have been collaborative efforts combining data from multiple
laboratories (5, 6). Antibody values assigned to 007sp in this study are based on the
data from one laboratory, and veriﬁcation by other laboratories would be important.
MATERIALS AND METHODS
Collection of human sera. The human pneumococcal standard reference serum, 007sp, was
developed as previously described (5). Sera from 16 donors who took part on the development of 007sp
were stored individually to act as new calibration sera (FDA OPA calibration sera) (11). Sera was found
to be free of HIV and hepatitis B and hepatitis C.
Laboratory methods. The concentrations of serotype-speciﬁc IgG1, IgG2, and IgA antibody present
in 007sp were inferred from the standard reference serum, lot 89SF, using the standardized pneumo-
coccal reference ELISA as previously described (12). Brieﬂy, 96-well ﬂat-bottomed microtiter plates were
coated with capsular polysaccharide antigens (ATCC; LGC Standards, Teddington, UK) from pneumococ-
cal serotypes 1, 3, 4, 5, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F. Both 89SF and 007sp were double absorbed
with CWPS and puriﬁed serotype 22F polysaccharide to neutralize the anti-cell wall polysaccharide and
nonspeciﬁc homologous antibodies to serotype 22F, as described in the WHO reference ELISA protocol
(13). Plates were washed, and a titration of the 007sp and lot 89SF was added. The unknown (007sp) was
run in duplicate through each ELISA a minimum of 18 times. Plates were incubated and washed again,
and prediluted alkaline phosphatase-conjugated goat anti-human IgA (Sigma-Aldrich Company, Ltd.),
alkaline phosphatase-conjugated mouse anti-human IgG1 (Abcam, Cambridge, UK), or alkaline
phosphatase-conjugated mouse anti-human IgG2 (Source BioScience, Nottingham, UK) was added to
each well. After a ﬁnal incubation, the plates were washed a ﬁnal time and p-nitrophenyl phosphate
substrate (Sigma-Aldrich Company, Ltd.) was added. The reaction was stopped by adding 3 M NaOH
(Thermo Fisher Scientiﬁc Oxoid, Ltd.) to each well. Plates were read using a microtiter plate reader
(SPECTROstar Omega; BMG Labtech, Ltd., Buckinghamshire, UK) at 405 and 690 nm.
In order to assess the accuracy of antibody assignments to 007sp, the concentration of serotype-
speciﬁc IgG1, IgG2, and IgA antibody in a panel of OPA calibration serum was measured using both
antibody standards and compared. A panel of 16 sera was run with both antibody standards three times
each, as described above.
FIG 2 Scatter plot showing the correlation (linear regression; dotted line) between previously assigned
serotype-speciﬁc IgG to 007sp and the sum of serotype-speciﬁc IgG1 and IgG2 to 007sp assigned in this
study. Each point represents geometric mean antibody concentrations for one pneumococcal capsular
serotype (individually labeled). R2  0.9546; P  2e–7; n 11 serotypes.
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Statistical analysis. For the assignment of values to 007sp, there were between 18 and 40
determinations of IgA, IgG1, and IgG2, respectively, for each capsular serotype. Serotype-speciﬁc IgA,
IgG1, and IgG2 values were estimated for each serotype with a linear-random-effects ANOVA model. All
models were ﬁtted independently of serotype, and 95% CIs were estimated by serotype. Data were
analyzed after log transformation of ELISA IgA, IgG1, and IgG2 concentrations. The geometric mean of
the log concentrations for each serotype was calculated using lot 89SF antibody concentrations and
estimated using ANOVA models obtained by back-transforming the estimated log-transformed concen-
trations and associated 95% CIs. Studentized residual plots were used to detect any outliers, which were
removed from the analysis of the ﬁnal assigned concentrations. All statistical analyses were performed
using Excel (version 16.0.4639.1000) for Windows.
Mean serotype-speciﬁc IgG1, IgG2, and IgA antibody values assigned to the FDA OPA calibration sera
panel, using both lot 89SF and 007sp antibody standards, were compared by calculating the coefﬁcient
of variation, the fold difference, and the correlation between interpolated antibody values for each
serotype (n 16 samples).
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
mSphere.00400-19.
TABLE S1, DOCX ﬁle, 0.02 MB.
FIG 3 Correlation between serotype-speciﬁc IgA (a), IgG1 (b), and IgG2 (c) log concentrations interpo-
lated using lot 89SF (y axis) and 007sp (x axis) as the standard is shown (n 16 samples run three times
each). The linear equations and R2 values for each assay are included. Each point (crosses) represents the
average log concentration for each sample after three experiments (n 11 serotypes).
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